Selected research
Industry Research
Histone Methyltransferases Industry Research Report 2026
Market perspective
The global Histone Methyltransferases market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Histone Methyltransferases is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Histone Methyltransferases is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Histone Methyltransferases is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Histone Methyltransferases include Eisai Co., Ltd., Pfizer, Glaxosmithkline (Gsk), Sirtris, Sigma-Aldrich, Sequenom, Inc., Ribomed Biotechnologies, Inc., Reaction Biology Corp. and Rana Therapeutics Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Histone Methyltransferases market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Histone Methyltransferases Market by Company
Eisai Co., Ltd.
Pfizer
Glaxosmithkline (Gsk)
Sirtris
Sigma-Aldrich
Sequenom, Inc.
Ribomed Biotechnologies, Inc.
Reaction Biology Corp.
Rana Therapeutics Inc.
Prognosdx Health, Inc.
Pharmacyclics, Inc
Epizyme, Inc.
Epitherapeutics APS
Domainex
Constellation Pharmaceuticals
Cellcentric Ltd.
Histone Methyltransferases Segment by Type
EZ
RIZ
SET1
SET2
SMYD
SUV39
SUV4-20
Histone Methyltransferases Segment by Application
Breast Cancer
Liver Cancer
Lung Cancer
Others
Histone Methyltransferases Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Histone Methyltransferases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Histone Methyltransferases and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Histone Methyltransferases.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Histone Methyltransferases manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Histone Methyltransferases by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Histone Methyltransferases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- EZ
- RIZ
- SET1
- SET2
- SMYD
- SUV39
- SUV4-20
Applications
- Breast Cancer
- Liver Cancer
- Lung Cancer
- Others
Companies covered
- Eisai Co., Ltd.
- Pfizer
- Glaxosmithkline (Gsk)
- Sirtris
- Sigma-Aldrich
- Sequenom, Inc.
- Ribomed Biotechnologies, Inc.
- Reaction Biology Corp.
- Rana Therapeutics Inc.
- Prognosdx Health, Inc.
- Pharmacyclics, Inc
- Epizyme, Inc.
- Epitherapeutics APS
- Domainex
- Constellation Pharmaceuticals
- Cellcentric Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Histone Methyltransferases Market Size (2021-2032)
- 2.2.2 Global Histone Methyltransferases Sales (2021-2032)
- 2.2.3 Global Histone Methyltransferases Market Average Price (2021-2032)
- 2.3 Histone Methyltransferases by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 EZ
- 2.3.3 RIZ
- 2.3.4 SET1
- 2.3.5 SET2
- 2.3.6 SMYD
- 2.3.7 SUV39
- 2.3.8 SUV4-20
- 2.4 Histone Methyltransferases by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Breast Cancer
- 2.4.3 Liver Cancer
- 2.4.4 Lung Cancer
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Histone Methyltransferases Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Histone Methyltransferases Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Histone Methyltransferases Revenue of Manufacturers (2021-2026)
- 3.4 Global Histone Methyltransferases Average Price by Manufacturers (2021-2026)
- 3.5 Global Histone Methyltransferases Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Histone Methyltransferases, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Histone Methyltransferases, Product Type & Application
- 3.8 Global Manufacturers of Histone Methyltransferases, Established Date
- 3.9 Global Histone Methyltransferases Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Eisai Co., Ltd.
- 4.1.1 Eisai Co., Ltd. Company Information
- 4.1.2 Eisai Co., Ltd. Business Overview
- 4.1.3 Eisai Co., Ltd. Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Eisai Co., Ltd. Histone Methyltransferases Product Portfolio
- 4.1.5 Eisai Co., Ltd. Recent Developments
- 4.2 Pfizer
- 4.2.1 Pfizer Company Information
- 4.2.2 Pfizer Business Overview
- 4.2.3 Pfizer Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Pfizer Histone Methyltransferases Product Portfolio
- 4.2.5 Pfizer Recent Developments
- 4.3 Glaxosmithkline (Gsk)
- 4.3.1 Glaxosmithkline (Gsk) Company Information
- 4.3.2 Glaxosmithkline (Gsk) Business Overview
- 4.3.3 Glaxosmithkline (Gsk) Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Glaxosmithkline (Gsk) Histone Methyltransferases Product Portfolio
- 4.3.5 Glaxosmithkline (Gsk) Recent Developments
- 4.4 Sirtris
- 4.4.1 Sirtris Company Information
- 4.4.2 Sirtris Business Overview
- 4.4.3 Sirtris Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sirtris Histone Methyltransferases Product Portfolio
- 4.4.5 Sirtris Recent Developments
- 4.5 Sigma-Aldrich
- 4.5.1 Sigma-Aldrich Company Information
- 4.5.2 Sigma-Aldrich Business Overview
- 4.5.3 Sigma-Aldrich Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sigma-Aldrich Histone Methyltransferases Product Portfolio
- 4.5.5 Sigma-Aldrich Recent Developments
- 4.6 Sequenom, Inc.
- 4.6.1 Sequenom, Inc. Company Information
- 4.6.2 Sequenom, Inc. Business Overview
- 4.6.3 Sequenom, Inc. Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sequenom, Inc. Histone Methyltransferases Product Portfolio
- 4.6.5 Sequenom, Inc. Recent Developments
- 4.7 Ribomed Biotechnologies, Inc.
- 4.7.1 Ribomed Biotechnologies, Inc. Company Information
- 4.7.2 Ribomed Biotechnologies, Inc. Business Overview
- 4.7.3 Ribomed Biotechnologies, Inc. Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Ribomed Biotechnologies, Inc. Histone Methyltransferases Product Portfolio
- 4.7.5 Ribomed Biotechnologies, Inc. Recent Developments
- 4.8 Reaction Biology Corp.
- 4.8.1 Reaction Biology Corp. Company Information
- 4.8.2 Reaction Biology Corp. Business Overview
- 4.8.3 Reaction Biology Corp. Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Reaction Biology Corp. Histone Methyltransferases Product Portfolio
- 4.8.5 Reaction Biology Corp. Recent Developments
- 4.9 Rana Therapeutics Inc.
- 4.9.1 Rana Therapeutics Inc. Company Information
- 4.9.2 Rana Therapeutics Inc. Business Overview
- 4.9.3 Rana Therapeutics Inc. Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Rana Therapeutics Inc. Histone Methyltransferases Product Portfolio
- 4.9.5 Rana Therapeutics Inc. Recent Developments
- 4.10 Prognosdx Health, Inc.
- 4.10.1 Prognosdx Health, Inc. Company Information
- 4.10.2 Prognosdx Health, Inc. Business Overview
- 4.10.3 Prognosdx Health, Inc. Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Prognosdx Health, Inc. Histone Methyltransferases Product Portfolio
- 4.10.5 Prognosdx Health, Inc. Recent Developments
- 4.11 Pharmacyclics, Inc
- 4.11.1 Pharmacyclics, Inc Company Information
- 4.11.2 Pharmacyclics, Inc Business Overview
- 4.11.3 Pharmacyclics, Inc Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Pharmacyclics, Inc Histone Methyltransferases Product Portfolio
- 4.11.5 Pharmacyclics, Inc Recent Developments
- 4.12 Epizyme, Inc.
- 4.12.1 Epizyme, Inc. Company Information
- 4.12.2 Epizyme, Inc. Business Overview
- 4.12.3 Epizyme, Inc. Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Epizyme, Inc. Histone Methyltransferases Product Portfolio
- 4.12.5 Epizyme, Inc. Recent Developments
- 4.13 Epitherapeutics APS
- 4.13.1 Epitherapeutics APS Company Information
- 4.13.2 Epitherapeutics APS Business Overview
- 4.13.3 Epitherapeutics APS Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Epitherapeutics APS Histone Methyltransferases Product Portfolio
- 4.13.5 Epitherapeutics APS Recent Developments
- 4.14 Domainex
- 4.14.1 Domainex Company Information
- 4.14.2 Domainex Business Overview
- 4.14.3 Domainex Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Domainex Histone Methyltransferases Product Portfolio
- 4.14.5 Domainex Recent Developments
- 4.15 Constellation Pharmaceuticals
- 4.15.1 Constellation Pharmaceuticals Company Information
- 4.15.2 Constellation Pharmaceuticals Business Overview
- 4.15.3 Constellation Pharmaceuticals Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Constellation Pharmaceuticals Histone Methyltransferases Product Portfolio
- 4.15.5 Constellation Pharmaceuticals Recent Developments
- 4.16 Cellcentric Ltd.
- 4.16.1 Cellcentric Ltd. Company Information
- 4.16.2 Cellcentric Ltd. Business Overview
- 4.16.3 Cellcentric Ltd. Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Cellcentric Ltd. Histone Methyltransferases Product Portfolio
- 4.16.5 Cellcentric Ltd. Recent Developments
5 Global Histone Methyltransferases Market Scenario by Region
- 5.1 Global Histone Methyltransferases Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Histone Methyltransferases Sales by Region: 2021-2032
- 5.2.1 Global Histone Methyltransferases Sales by Region: 2021-2026
- 5.2.2 Global Histone Methyltransferases Sales by Region: 2027-2032
- 5.3 Global Histone Methyltransferases Revenue by Region: 2021-2032
- 5.3.1 Global Histone Methyltransferases Revenue by Region: 2021-2026
- 5.3.2 Global Histone Methyltransferases Revenue by Region: 2027-2032
- 5.4 North America Histone Methyltransferases Market Facts & Figures by Country
- 5.4.1 North America Histone Methyltransferases Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Histone Methyltransferases Sales by Country (2021-2032)
- 5.4.3 North America Histone Methyltransferases Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Histone Methyltransferases Market Facts & Figures by Country
- 5.5.1 Europe Histone Methyltransferases Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Histone Methyltransferases Sales by Country (2021-2032)
- 5.5.3 Europe Histone Methyltransferases Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Histone Methyltransferases Market Facts & Figures by Country
- 5.6.1 Asia Pacific Histone Methyltransferases Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Histone Methyltransferases Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Histone Methyltransferases Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Histone Methyltransferases Market Facts & Figures by Country
- 5.7.1 South America Histone Methyltransferases Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Histone Methyltransferases Sales by Country (2021-2032)
- 5.7.3 South America Histone Methyltransferases Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Histone Methyltransferases Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Histone Methyltransferases Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Histone Methyltransferases Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Histone Methyltransferases Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Histone Methyltransferases Sales by Type (2021-2032)
- 6.1.1 Global Histone Methyltransferases Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Histone Methyltransferases Sales Market Share by Type (2021-2032)
- 6.2 Global Histone Methyltransferases Revenue by Type (2021-2032)
- 6.2.1 Global Histone Methyltransferases Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Histone Methyltransferases Revenue Market Share by Type (2021-2032)
- 6.3 Global Histone Methyltransferases Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Histone Methyltransferases Sales by Application (2021-2032)
- 7.1.1 Global Histone Methyltransferases Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Histone Methyltransferases Sales Market Share by Application (2021-2032)
- 7.2 Global Histone Methyltransferases Revenue by Application (2021-2032)
- 7.2.1 Global Histone Methyltransferases Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Histone Methyltransferases Revenue Market Share by Application (2021-2032)
- 7.3 Global Histone Methyltransferases Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Histone Methyltransferases Value Chain Analysis
- 8.1.1 Histone Methyltransferases Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Histone Methyltransferases Production Mode & Process
- 8.2 Histone Methyltransferases Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Histone Methyltransferases Distributors
- 8.2.3 Histone Methyltransferases Customers
9 Global Histone Methyltransferases Analyzing Market Dynamics
- 9.1 Histone Methyltransferases Industry Trends
- 9.2 Histone Methyltransferases Industry Drivers
- 9.3 Histone Methyltransferases Industry Opportunities and Challenges
- 9.4 Histone Methyltransferases Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst